• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1982 …2021

Research activity per year

If you made any changes in Pure these will be visible here soon.
Filter
Chapter

Search results

  • 2015

    Bile acid sequestrants: Risk– benefits and role in treating dyslipidemias

    Ganda, O. P. & Garg, A., Jan 1 2015, Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., p. 453-463 11 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    1 Scopus citations
  • Lipodystrophies and dyslipidemias

    Garg, A., Jan 1 2015, Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., p. 287-302 16 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    2 Scopus citations
  • Novel lipid-lowering agents

    Ahmad, Z. & Garg, A., Jan 1 2015, Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., p. 499-519 21 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • 2013

    Genetic lipodystrophies

    Garg, A., 2013, Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier Ltd, p. 1-16 16 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    1 Scopus citations